Abstract
Strokes are the fifth leading cause of death in the United States and can cause long-term disabilities in patients who survive a stroke. The vast majority of these strokes are ischemic, primarily caused by intracranial atherosclerosis. Most therapies to combat intracranial atherosclerosis simply manage it and do not remove the buildup of plaque. Targeted shear-activated nano-therapeutics are currently being developed to remove these plaques. We discuss the roles that aggregate particle density, aggregate particle diameter, vessel geometry, stenosis shape, and breakup threshold play in the efficiency of this new technology. Computational studies were performed to test these parameters in three idealized vessels with varying curvatures (straight, quarter-circle, semi-circle) and two different stenosis shapes (concentric, eccentric). We find that curvature plays a large role in the breakup threshold. The optimal breakup threshold for a semi-circular shaped vessel is 4.5 times that of a straight vessel, yet the less curved quarter-circle shaped vessel has an optimal breakup threshold that is 6.3 times that of the straight vessel. Therefore, no quantifiable pattern was discovered between geometry curvature and optimal threshold value. Curvature also plays a large role in how particle diameter affects the efficiency of these nano-therapeutics. Although the effects of particle size between 1 and 5 μm is minimal, the optimal particle diameter for a straight vessel was located at the smallest end of the tested range while the optimal diameter for the curved case was located at the largest end of the tested range. Particle-specific density was explored and found to have a negligible effect. Finally, curvature and stenosis location (superior, inferior, and ventral/dorsal) play a large role in optimizing breakup position. It is optimal for the stenosis to be in the path of the aggregate particle.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
T.E. Nogles, M.A. Galuska, Middle Cerebral Artery Stroke, in StatPearls, 2021 [Internet] (StatPearls Publishing, Treasure Island, 2022). PMID: 32310592
S.S. Virani, A. Alonso, E.J. Benjamin, M.S. Bittencourt, C.W. Callaway et al.. American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 141(9), e139–e596 (2020). https://doi.org/10.1161/CIR.0000000000000757. PMID: 31992061
N.P. Denswil, A.C. van der Wal, K. Ritz, O.J. de Boer, E. Aronica, D. Troost, M.J.A.P. Daemen, Atherosclerosis in the circle of Willis: spatial differences in composition and in distribution of plaques. Atherosclerosis 251, 78–84 (2016). https://doi.org/10.1016/j.atherosclerosis.2016.05.047. PMID: 27288902
Circle of Willis, Medlineplus Medical Encyclopedia. MedlinePlus, U.S. National Library of Medicine. Accessed 29 March 2021
A.E. Roher, C. Esh, T.A. Kokjohn, W. Kalback, D.C. Luehrs, J.D. Seward, L.I. Sue, T. G. Beach, Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer’s disease. Arteriosclerosis Thrombosis Vasc. Biol. 23(11), 2055–2062 (2003). PMID: 14617615
B. Flusty, A. de Havenon, S. Prabhakaran, D.S. Liebeskind, S. Yaghi, Intracranial atherosclerosis treatment: past, present, and future. Stroke 51(3), e49–e53 (2020). https://doi.org/10.1161/strokeaha.119.028528. PMID: 32078441
R. Olie, P. van der Meijden, H.M.H. Spronk, H.T. Cate, Antithrombotic therapy: prevention and treatment of atherosclerosis and atherothrombosis, in Handbook of Experimental Pharmacology (2020)
B.B. Adhyaru, T.A. Jacobson, Safety and efficacy of statin therapy. Nat. Rev. Cardiol. 15(12), 757–769 (2018). https://doi.org/10.1038/s41569-018-0098-5. PMID: 30375494
G. Doig, G.H. Yeoh, V. Timchenko, G. Rosengarten, T.J. Barber, S.C. Cheung, Simulation of blood flow and nanoparticle transport in a stenosed carotid bifurcation and pseudo-arteriole. J. Comput. Multiphase Flows 4(1), 85–101 (2012)
N. Korin, M. Kanapathipillai, B.D. Matthews, M. Crescente, A. Brill, T. Mammoto, K. Ghosh, S. Jurek, S.A. Bencherif, D. Bhatta, A.U. Coskun, C.L. Feldman, D.D. Wagner, D.E. Ingber, Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 337(6095), 738–42 (2012). https://doi.org/10.1126/science.1217815. Erratum in: Science 337(6101), 1453 (2012). PMID: 22767894
M.G. Marosfoi, N. Korin, M.J. Gounis, O. Uzun, S. Veantham, E.T. Langan, A.l. Papa, O.W. Brooks, C. Johnson, A.S. Puri, D. Bhatta, M. Kanapathip-illai, B.R. Bronstein, J.Y. Chueh, D.E. Ingber, A.K. Wakhloo, Shear-activated nanoparticle aggregates combined with temporary endovascular bypass to treat large vessel occlusion. Stroke 46(12), 3507–3513 (2015). PMID: 26493676
The crucial, controversial carotid artery part I: The artery in health and disease. Harvard Health (2011). Accessed 29 March 2021
H.J. Barnett, D.W. Taylor, M. Eliasziw, A.J. Fox, G.G. Ferguson, R.B. Haynes, R.N. Rankin, G.P. Clagett, V.C. Hachinski, D.L. Sackett, K.E. Thorpe, H.E. Meldrum, J.D. Spence, Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 339(20), 1415–25 (1998). https://doi.org/10.1056/NEJM199811123392002. PMID: 9811916
Y. Qiao, Y. Wang, Y. Chen, K. Luo, J. Fan, Mathematical modeling of shear-activated targeted nanoparticle drug delivery for the treatment of aortic diseases. Biomech. Model. Mechanobiol. 21(1), 221–230 (2022). https://doi.org/10.1007/s10237-021-01530-9. PMID: 34748063
Freecad. https://www.freecadweb.org/
R. Lohner, Automatic unstructured grid generators. Finite Ele. Anal. Design 25, 111–134 (1997)
R. Lohner, Renumbering strategies for unstructured grid solvers operating onshared memory, cached based parallel machines. Comput. Methods Appl. Mech. Eng. 163, 95–109 (1998)
J.R. Cebral, R. Lohner, S. Appananboyina, C.M., Putman, Image-based computational hemodynamics methods and their application for the analysis of blood flow past endovascular devices, in Biomechanical Systems Technology: Computational Methods (WorldScientific, Singapore, 2007), pp. 29–85
F. Mut, Fast numerical solutions of patient-specific blood flows in 3D arterialsystems. Int. J. Num. Methods Biomed. Eng. 26(1), 73–85 (2010)
B.J. Chung, D. Platt, A. Vaidya, The mechanics of clearance in a non-Newtonian lubrication layer. Int. J. Non-Linear Mech. 86, 133–145 (2016)
S. Meschi, A. Farghadan, A. Arzani, Flow topology and targeted drug delivery in cardiovascular disease. J. Biomech. 119, 110307 (2021). https://doi.org/10.1016/j.jbiomech.2021.110307
R.C. Becker, The role of blood viscosity in the development and progression of coronary artery disease. Cleveland Clin. J. Med. 60(5), 53–358 (1993)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jefopoulos, N., Chung, B.J. (2022). Computational Analysis to Study the Efficiency of Shear-Activated Nano-Therapeutics in the Treatment of Atherosclerosis. In: Carapau, F., Vaidya, A. (eds) Recent Advances in Mechanics and Fluid-Structure Interaction with Applications. Advances in Mathematical Fluid Mechanics. Birkhäuser, Cham. https://doi.org/10.1007/978-3-031-14324-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-031-14324-3_14
Published:
Publisher Name: Birkhäuser, Cham
Print ISBN: 978-3-031-14323-6
Online ISBN: 978-3-031-14324-3
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)